Pharmaceutical and Medical Devices Supply Chain Priorities Explored in New Report

Share Article

eft have released the 2014 Life Sciences Supply Chain Report Series, exploring pharmaceutical, medical devices and solution provider SCM challenges and priorities for the next 12 months.

Split into 3 parts (pharma, medical devices and solution provider views) the report provides a comprehensive look at challenges and priorities for life sciences executives over the coming 12 months - exploring globalization, regulation and areas for competitive advantage. The report also looks at the impact of more future-looking trends such as big data, direct-to-consumer delivery and M&A - a useful benchmarking tool when comparing your operations to competitors and other segments of the life sciences supply chain.

The report also looks at customer-supplier relationships, comparing responses in order to pinpoint differences and synergies between objectives and challenges.

You can see the view and download the report immediately and for free here.

Results Include:

  • 58% of pharmaceutical manufacturer respondents carry out direct-to-customer deliveries. The biggest benefit of this? It enables the manufacturer to move closer to the patient
  • Only 4% of medical devices SCM executives rate their visibility capabilities as ‘excellent’
  • The lack of healthcare-specific capabilities is the main challenge that 3PLs believe their customers face when selecting a 3PL

The issues raised in this report will be discussed at the Life Sciences Supply Chain Summit, taking place in Amsterdam this December 3-4. Senior supply chain executives working at a pharmaceutical or medical devices manufacturer can attend the event with a complimentary pass.

For more information on the event, see the event website or contact the event organizer, Sarah Reynolds on sreynolds(at)eft(dot)com ; +44 (0)207 375 7243

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah Reynolds
Follow >
eft Supply Chain & Logistics Intelligence

Visit website